Description
Alluvi Retatrutide 40mg – High-Capacity Triple Agonist Research System
Conduct high-level metabolic studies with the maximum-capacity Alluvi Retatrutide 40mg. Representing the pinnacle of modern incretin research, Retatrutide delivers an elite triple agonist multi-pathway mechanism that simultaneously targets GLP-1, GIP, and Glucagon receptors.
By activating all three distinct receptor pathways at a robust concentration, this formulation allows researchers to observe synergistic metabolic performance, receptor saturation limits, and cellular lipid metabolism in advanced laboratory models.
This premium kit features a high-capacity, pre-filled dispensing pen mechanism explicitly engineered for absolute precision, sterility, and experimental convenience.
Key Features for Researchers
•High-Concentration Triple Agonist: Simultaneously activates GLP-1, GIP, and Glucagon receptors for comprehensive, multi-angle metabolic studies.
•Pre-Filled Pen Delivery System: Ready-to-use solution requiring zero manual reconstitution, mixing, or complex syringe calculations.
•High-Capacity 40mg Kit: Tailored for advanced research regimens or sustained observational cycles.
•Seamless Application: Engineered for smooth, fast, and consistent volumetric dispensing.
Product Specifications
•Total Capacity: 40mg per box
•Dose Configuration: 4 precise volumetric yields of 10mg each
•Format: Solution inside a premium pre-filled dial pen
•Application: For laboratory research and in-vitro use only
Storage & Handling Instructions
•Temperature Control: To sustain structural peptide integrity and peak purity, this product must be kept refrigerated at 2°C to 8°C. Do not freeze.
•Handling: Always read the included technical leaflet entirely prior to first use to learn how to properly turn the dial mechanism and safely dispense the compound.
⚠️ Research Disclaimer: This product is strictly for research and laboratory purposes only. It is not intended for human consumption, animal use, or medical application. All researchers must handle this compound in accordance with institutional safety protocols.
